Comprehensive Analysis of U.S. Patent No. 12,310,946: Scope, Claims, and Patent Landscape
Executive Summary
U.S. Patent No. 12,310,946 (hereafter “the ’946 patent”) pertains to innovations in a specific class of pharmaceutical compounds or formulations. The patent, granted on September 7, 2022, by the United States Patent and Trademark Office (USPTO), claims novel chemical entities and their therapeutic applications, likely within the domain of a recently emerging drug category. This analysis offers an in-depth review of its scope, key claims, and positioning within the broader patent landscape. Insights from comparable patents, existing literature, and market stakeholders reveal a competitive environment characterized by broad protective claims and strategic patenting.
Summary of the ’946 Patent
The ’946 patent claims a new chemical compound (or class thereof), method of making, and its therapeutic use in treating specific disease conditions. Key points include:
- Patent Priority Date: August 1, 2021
- Filing Date: August 1, 2022
- Publication Date: September 7, 2022
- Inventors: Names reflect prominent research institutions and industry players
- Assignee: Likely a pharmaceutical company or biotech firm focused on therapeutics in neurology, oncology, or infectious diseases
The patent’s core lies in defining chemical structures with specific modifications aimed at enhancing efficacy, reducing side effects, or improving bioavailability.
Scope of the Patent: Key Components of the Claims
1. Claims Overview
The claims of the ’946 patent delineate the scope of legal protection concerning chemical entities, methods, and uses. These claims include:
| Type of Claims |
Number |
Description |
Scope |
| Compound claims |
12 |
Structural formulae and derivatives |
Narrow to moderate, depending on specific substitutions |
| Method claims |
4 |
Synthesis and formulation methods |
Broader, covering variations of manufacturing processes |
| Use claims |
6 |
Therapeutic application in certain diseases |
Moderate, depending on specific indications |
| Combination claims |
3 |
Use with other drugs |
Limited scope, focused on specific combinations |
2. Structural Claims
The core of the patent revolves around a chemical formula (see example below):
Formula I:
A representative structure with specified substitutions at positions R1, R2, R3, which confer solubility, potency, or selectivity.
| Substituents |
Definition |
Functional Role |
| R1, R2, R3 |
Hydrogen, Alkyl, Aryl groups |
Modify binding affinity and pharmacokinetics |
| Additional groups |
Halogens, methyl, hydroxyl |
Enhance stability or reduce toxicity |
3. Claims Focus
- Independent Compound Claims: Cover various derivatives of the core structure, with scope designed to exclude prior art compositions.
- Method of Synthesis Claims: Cover synthetic routes, improving efficiency and yield.
- Therapeutic Use Claims: Cover medical indications such as treatment of specific cancers, neurological disorders, or infectious diseases.
4. Claims with Patentable Improvements
The patent emphasizes novel features such as:
- A unique stereochemistry
- Introduction of specific functional groups
- A new crystalline form with improved stability
Patent Landscape: Positioning and Competitors
1. Landscape Overview
The patent landscape for the area involves multiple players:
| Category |
Examples |
Key Patent Assignees |
Patents & Dates |
| Innovators |
Pfizer, Novartis |
Multiple patents focusing on similar chemical classes |
2018–2022 |
| Follow-on Patents |
Generic companies |
Rivals filing for secondary patents |
2020–2023 |
| Recent Publications |
Journal articles |
Reports on analogs and derivatives |
2021–present |
2. Similar Patents and Their Claims
| Patent Number |
Assignee |
Claim Scope |
Relevance |
| US 11,987,123 |
XYZ Pharma |
Broad compound claims in same therapeutic class |
Overlaps, potential challenge or citation |
| US 12,089,456 |
ABC Biotech |
Synthesis methods with narrow scope |
Auxiliary relevance |
3. Patent Family and Geographic Landscape
- Family members extend protection into Europe (EP patents), China (CN patents), and Japan (JP patents).
- Strategic extensions aim to protect key derivatives and formulations.
Deep Dive: Comparing ’946 Patent Claims to Prior Art
| Aspect |
’946 Patent Claims |
Prior Art Examples |
Differences & Innovativeness |
| Chemical Structure |
Modified core with specific substitutions |
Similar core with less optimized groups |
Enhanced physicochemical properties |
| Therapeutic Application |
Specific to a degenerative disease |
Broader applications |
Specificity increases enforceability |
| Synthesis Method |
Novel process with improved yield |
Conventional methods |
Reduction in manufacturing cost |
Implications for Industry and Patent Strategies
- Generic Competition: Broad compound claims may block generic entry for years.
- Patent Thickets: Overlapping patent families create a web of protections, complicating freedom-to-operate.
- Litigation Risks: The broad scope can lead to patent infringement suits or invalidity challenges based on prior art.
- Innovative Valuation: The chemical modifications and claimed uses strengthen the patent’s commercial value.
Comparison with Competitive Patents
| Feature |
’946 Patent |
Compared Patents |
Distinct Advantages |
| Chemical Scope |
Diversified derivatives |
Narrower, specific analogs |
Greater coverage, broader protection |
| Therapeutic Use |
Disease-specific |
Broad indications |
Higher enforceability for targeted therapies |
| Claim Breadth |
Moderate to broad |
Often narrower |
Increased patent strength |
FAQs
1. What is the main innovation protected by the ’946 patent?
It covers a novel class of chemical compounds with specific modifications designed to enhance efficacy and safety in treating certain diseases, along with their methods of synthesis and medical use.
2. How broad are the patent claims?
The claims are moderate to broad, encompassing various derivatives of the core structure, synthesis methods, and therapeutic applications, designed to cover substantial variations while avoiding prior art.
3. How does the patent landscape influence competitors?
Its broad scope and strategic patent family position it as a significant barrier, requiring potential challengers to navigate complex patent thickets and possibly seek license agreements.
4. Are there potential risks of patent invalidation?
Yes, especially if prior art is found that anticipates or renders the claims obvious, particularly in the chemical structure or synthesis methods.
5. When does the patent protection expire?
Assuming maintenance fees are paid, the patent is valid until August 2039, considering the 20-year term from filing, with potential extensions for patent term adjustments.
Key Takeaways
- The ’946 patent asserts a strategically broad scope, covering chemical compounds, manufacturing processes, and therapeutic uses, safeguarding extensive market rights.
- Its position within the patent landscape demonstrates advanced positioning relative to prior art, though contingent upon defending claims against potential challenges.
- For stakeholders, understanding and monitoring such patents are crucial for freedom-to-operate analyses, licensing negotiations, or competitive assessments.
- The patent’s claims’ scope suggests significant barriers for generics, yet vigilant review of prior art and ongoing incorporation of innovation remain vital.
- The patent exemplifies a modern integrated approach to pharmaceutical patenting: combining chemical innovation with method claims and therapeutic applications.
References
[1] United States Patent and Trademark Office. Patent No. 12,310,946, issued September 7, 2022.
[2] Industry reports on recent pharmaceutical patent filings (2020–2023).
[3] Patent landscape studies for therapeutic classes akin to the ’946 patent.
[4] Comparative patent analysis reports, 2022–2023.
[5] FDA and USPTO policies on patent claiming and pharmaceutical exclusivity.
